The long-term goal of the Laboratory for Regenerative Medicine and Applied Sciences is to develop a functional hybrid graft to heal full-thickness skin defects and explore the potential of epithelial-derived stem cells (LGR5+ and  LGR6+) for burns, neuropathic ulcers, and hair regeneration.

We are also exploring the potential of merging TRAIL (TNF-Related Apoptosis-Inducing Ligand) therapy with conventional breast reconstruction procedures to eliminate breast cancer recurrence after mastectomy.